An elementary approach to modeling drug resistance in cancer
From MaRDI portal
Publication:1942405
DOI10.3934/mbe.2010.7.905zbMath1259.92056OpenAlexW1993636487WikidataQ37425081 ScholiaQ37425081MaRDI QIDQ1942405
Cristian Tomasetti, Doron Levy
Publication date: 19 March 2013
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2010.7.905
Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)
Related Items (20)
Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors ⋮ AN ADAPTIVE PHARMACOKINETIC OPTIMAL CONTROL APPROACH IN CHEMOTHERAPY FOR HETEROGENEOUS TUMOR ⋮ Optimal therapy scheduling based on a pair of collaterally sensitive drugs ⋮ A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence ⋮ Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy ⋮ Mathematical modeling and bifurcation analysis for a biological mechanism of cancer drug resistance ⋮ A two-phenotype model of immune evasion by cancer cells ⋮ An elementary mathematical modeling of drug resistance in cancer ⋮ Theoretical modeling of collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy ⋮ Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth ⋮ On the probability of random genetic mutations for various types of tumor growth ⋮ The impact of cell density and mutations in a model of multidrug resistance in solid tumors ⋮ Large population solution of the stochastic Luria–Delbrück evolution model ⋮ Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers ⋮ Modeling continuous levels of resistance to multidrug therapy in cancer ⋮ Опухолевый рост и возможности математического моделирования системных процессов ⋮ A stochastic individual-based model to explore the role of spatial interactions and antigen recognition in the immune response against solid tumours ⋮ A multi-drug pharmacokinectic optimal control approach in cancer chemotherapy ⋮ Scaling solution in the large population limit of the general asymmetric stochastic Luria-Delbrück evolution process ⋮ Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
This page was built for publication: An elementary approach to modeling drug resistance in cancer
